Large-scale testing (Phase 3)Study completedNCT00145002What this trial is testingAggressive Adult T-cell Leukemia-lymphoma (ATLL)Who this might be right forAdult T-cell LeukemiaLymphoma Japan Clinical Oncology Group 130
Testing effectiveness (Phase 2)Study completedNCT00462605What this trial is testingMS-275 and GM-CSF in Treating Patients With Myelodysplastic Syndrome and/or Relapsed or Refractory Acute Myeloid Leukemia or Acute Lymphocytic LeukemiaWho this might be right forAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Megakaryoblastic Leukemia (M7)Adult Acute Minimally Differentiated Myeloid Leukemia (M0)+25 more National Cancer Institute (NCI) 24
Testing effectiveness (Phase 2)UnknownNCT03467256What this trial is testingCD19 T-CAR for Treatment of Children and Young Adults With r/r B-ALLWho this might be right forB-cell Acute Lymphoblastic LeukemiaAcute Lymphocytic Leukemia, Pediatric Federal Research Institute of Pediatric Hematology, Oncology and Immunology 18
Not applicableUnknownNCT04120896What this trial is testingKarate or Kung Fu?Who this might be right forChildhood ALL The University of Hong Kong 52
Early research (Phase 1)WithdrawnNCT05037669What this trial is testingProgrammed Allogeneic CRISPR-edited T Cells Engineered to Express Anti-CD19 Chimeric Antigen Receptor (PACE CART19) in Patients With Relapsed Or Refractory CD19+ Leukemia and LymphomaWho this might be right forAcute Lymphoblastic LeukemiaChronic Lymphocytic LeukemiaNon Hodgkin Lymphoma University of Pennsylvania
Testing effectiveness (Phase 2)Study completedNCT00005854What this trial is testingBone Marrow Transplantation in Treating Patients With Hematologic CancerWho this might be right forLeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more Fred Hutchinson Cancer Center
Testing effectiveness (Phase 2)Looking for participantsNCT07410494What this trial is testingBiomarker-Guided Allogeneic Single-Target or Dual-Target CAR-NK Cell Therapy for Advanced Solid TumorsWho this might be right forCancerBreast CancerNon-Small Cell Lung Cancer (NSCLC)+10 more Essen Biotech 85
Large-scale testing (Phase 3)Study completedNCT00408005What this trial is testingCombination Chemotherapy in Treating Young Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic LymphomaWho this might be right forT Acute Lymphoblastic LeukemiaT Lymphoblastic Lymphoma National Cancer Institute (NCI) 1,895
Testing effectiveness (Phase 2)Study completedNCT00005080What this trial is testing506U78 in Treating Patients With LymphomaWho this might be right forAnaplastic Large Cell LymphomaAngioimmunoblastic T-cell LymphomaRecurrent Adult T-cell Leukemia/Lymphoma+11 more National Cancer Institute (NCI) 74
Testing effectiveness (Phase 2)WithdrawnNCT03739606What this trial is testingFlotetuzumab in Treating Patients With Recurrent or Refractory CD123 Positive Blood CancerWho this might be right forAcute Biphenotypic LeukemiaAcute LeukemiaChronic Myelogenous Leukemia, BCR-ABL1 Positive+12 more City of Hope Medical Center
Large-scale testing (Phase 3)Looking for participantsNCT06764238What this trial is testingNewly-diagnosed Intermediate/High Risk Pediatric B-cell ALL ProtocolWho this might be right forAcute Lymphoblastic Leukemia ALLChildhood Leukemia, Acute LymphoblasticB Cell Acute Lymphoblastic Leukemia (B-ALL) Institute of Hematology & Blood Diseases Hospital, China 1,800
Early research (Phase 1)Ended earlyNCT00430443What this trial is testingLiposomal Annamycin in Children and Young Adults With Refractory or Relapsed ALL or AMLWho this might be right forAcute Lymphocytic LeukemiaAcute Myelogenous Leukemia Callisto Pharmaceuticals 3
Early research (Phase 1)Ended earlyNCT00882076What this trial is testingClofarabine, Etoposide, and Mitoxantrone for Relapsed and Refractory Acute LeukemiasWho this might be right forLeukemia Milton S. Hershey Medical Center 22
Early research (Phase 1)UnknownNCT01619761What this trial is testingNK Cells in Cord Blood TransplantationWho this might be right forAccelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 PositiveAcute Biphenotypic LeukemiaAcute Lymphoblastic Leukemia in Remission+22 more M.D. Anderson Cancer Center 13
Not applicableActive Not RecruitingNCT03154346What this trial is testingProject Baseline Health StudyWho this might be right forAll Baseline Study LLC 10,000
Testing effectiveness (Phase 2)Study completedNCT00004061What this trial is testingBiological Therapy in Treating Patients Undergoing Radiation Therapy, Chemotherapy, and Peripheral Stem Cell Transplantation for Hematologic CancerWho this might be right forLeukemiaLymphomaOral Complications Memorial Sloan Kettering Cancer Center 111
Early research (Phase 1)Looking for participantsNCT06709469What this trial is testingPhase I Clinical Trial of CART Cell Therapy for Refractory/Relapsed Acute Lymphoblastic Leukemia in Children, Adolescents and Young AdultsWho this might be right forPrecursor Cell Lymphoblastic Leukemia-Lymphoma Instituto de Investigación Hospital Universitario La Paz 10
Early research (Phase 1)Study completedNCT00562380What this trial is testingAMG-479 in Treating Patients With Advanced Solid Tumors or Non-Hodgkin LymphomaWho this might be right forLymphomaProstate CancerSarcoma+2 more Amgen 64
Early research (Phase 1)Study completedNCT00049296What this trial is testingThalidomide and Docetaxel in Treating Patients With Advanced CancerWho this might be right forCancer Case Comprehensive Cancer Center 26
Testing effectiveness (Phase 2)Study completedNCT00560794What this trial is testingPhase II Study of the BiTE® Blinatumomab (MT103) in Patients With Minimal Residual Disease of B-precursor Acute Lymphoblastic Leukemia (ALL)Who this might be right forAcute Lymphoblastic Leukemia Amgen Research (Munich) GmbH 21